PharmacyCodes



Estramustinum [Inn-Latin] en es it fr

Estramustinum [Inn-Latin] Brand names, Estramustinum [Inn-Latin] Analogs

Estramustinum [Inn-Latin] Brand Names Mixture

  • No information avaliable

Estramustinum [Inn-Latin] Chemical_Formula

C23H31Cl2NO3

Estramustinum [Inn-Latin] RX_link

http://www.rxlist.com/cgi/generic2/estramustine.htm

Estramustinum [Inn-Latin] fda sheet

Estramustinum_[Inn-Latin] FDA

Estramustinum [Inn-Latin] msds (material safety sheet)

Estramustinum [Inn-Latin] Synthesis Reference

No information avaliable

Estramustinum [Inn-Latin] Molecular Weight

440.403 g/mol

Estramustinum [Inn-Latin] Melting Point

104.5 oC

Estramustinum [Inn-Latin] H2O Solubility

No information avaliable

Estramustinum [Inn-Latin] State

Solid

Estramustinum [Inn-Latin] LogP

4.636

Estramustinum [Inn-Latin] Dosage Forms

Capsule

Estramustinum [Inn-Latin] Indication

For the palliative treatment of patients with metastatic and/or progressive carcinoma of the prostate

Estramustinum [Inn-Latin] Pharmacology

Estramustine is an antineoplastic agent indicated in the palliative treatment of patients with metastatic and/or progressive carcinoma of the prostate. Estramustine is a combination of estradiol with nornitrogen mustard. The precise mechanism of action of estramustine is unknown. Unlike other alkylating agents, estramustine does not directly damage DNA.

Estramustinum [Inn-Latin] Absorption

No information avaliable

Estramustinum [Inn-Latin] side effects and Toxicity

No information avaliable

Estramustinum [Inn-Latin] Patient Information

No information avaliable

Estramustinum [Inn-Latin] Organisms Affected

Humans and other mammals